Categories Uncategorized

Healthcare Providers Exhibiting PTSD Symptoms Similar to Veterans’

Recent studies have found that first responders and healthcare workers are displaying symptoms of PTSD that are similar to veterans who have served in combat.

Researchers and healthcare providers believe that if administrators fail to find ways to offer relief to medical staff and hospitals that continue to be overwhelmed with COVID patients, many healthcare workers will leave areas where they care for coronavirus patients or leave the healthcare sector completely. This would further strain the capacity of hospitals to offer necessary care while staffing shortages increase.

Dr. Rebecca Hendrickson, a VA Puget Health Care System clinical psychiatrist, stated that thinking of and taking care of healthcare workers was important not only because they mattered as people but also because their mental health has considerable implications for the healthcare system. Hendrickson, who’s leading a new study on healthcare workers, noted that protecting the healthcare system wouldn’t be possible without protecting its workers.

A survey conducted last year found that since February 2020, 30% of healthcare workers in America had quit or lost their jobs, the most common reason being the pandemic. Findings from a separate study that was published in December which surveyed more than 500 first responders, nurses and doctors discovered that 15% stated that they would likely not work in the field in the next decade. This figure was slightly higher — 20% — for nurses specifically.

Researchers believe that this is mainly due to the deterioration of the mental health of healthcare providers, with 74% of those who took part in the survey reporting symptoms of depression. Another 15% reported thoughts of self-harm or suicide while another 37% reported post-traumatic stress disorder symptoms.

Hendrickson noted that a huge contributor to the distress of healthcare providers was the coronavirus pandemic’s duration. At the start of the pandemic, there was a limited quantity of personal protective equipment and vaccines weren’t available, which left workers with a real risk of becoming ill, yet they still continued to provide care to patients. Now, even with more than one-half of hospital workers being vaccinated, these providers are still treating coronavirus patients who are seriously ill, many because they haven’t been vaccinated.

Hendrickson explained that the risk level reducing because of vaccinations and the omicron variant being less severe than other coronavirus variants was a relief to most healthcare providers. However, being asked to continue taking a risk, even when it didn’t feel necessary, caused a lot of distress and made it even harder to handle.

With cases of mental health conditions increasing at a high rate, especially in the wake of the pandemic, there is an urgent need for the novel medicines being developed by companies such as Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: MYCOF) because these new therapeutics promise to disrupt mental health care as we know it.

NOTE TO INVESTORS: The latest news and updates relating to Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: MYCOF) are available in the company’s newsroom at https://ibn.fm/MYCOF

About BioMedWire

BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.

To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.biomedwire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer

BioMedWire (BMW)
San Francisco, California
www.biomedwire.com
415.949.5050 Office
Editor@BioMedWire.com

BioMedWire is part of the InvestorBrandNetwork.

Chris@BMW

Share
Published by
Chris@BMW

Recent Posts

Soligenix Inc. (NASDAQ: SNGX) Strengthens Advisory Leadership in Cutaneous T-Cell Lymphoma

Soligenix revealed updates to its U.S. Medical Advisory Board for CTCL designed to support the…

20 hours ago

Sapu Nano Reveals the Initial In-Human Clinical Trial of Sapu-003, Intravenous Everolimus (Afinitor(R)) at Australian Translational Breast Cancer Symposium

The company revealed the trial at the Australia Translational Breast Cancer Research Symposium (“ATBCR”) Sapu-003…

21 hours ago

How Rural Health Care is Being Impacted by the Federal Funding Landscape

Approximately 20% of people in the U.S. live in a rural area, and they face…

4 days ago

$37.5M Grant Announced to Boost Management of Infectious Diseases in the US

On October 15, NETEC (National Emerging Special Pathogens Training & Education Center) announced a grant…

5 days ago

What Patients Need to Know About the Remission Rate of Glioblastomas

Patients are overwhelmed when they are diagnosed with glioblastoma, the most deadly primary brain cancer.…

7 days ago

Soligenix Inc. (NASDAQ: SNGX) Research Highlights Breakthrough in High-Temperature Vaccine Stability

Thermostable vaccine technology is considered a significant unmet need in epidemic preparedness. Soligenix has been…

7 days ago